Global Corticosteroid Medication market size is predicted to grow from US$ 5376 million in 2025 to US$ 7196 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.

Global Corticosteroid Medication Market Trends, Growth and Outlook 2025-31

The global Corticosteroid Medication market size is predicted to grow from US$ 5376 million in 2025 to US$ 7196 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031. Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma. Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market. Infinity Market Research newest research report, the Corticosteroid Medication Industry Forecast looks at past sales and reviews total world Corticosteroid Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Corticosteroid Medication sales for 2025 through 2031. With Corticosteroid Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corticosteroid Medication industry. This Insight Report provides a comprehensive analysis of the global Corticosteroid Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Corticosteroid Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Corticosteroid Medication market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corticosteroid Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corticosteroid Medication. This report presents a comprehensive overview, market shares, and growth opportunities of Corticosteroid Medication market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Tablets &nbsp;&nbsp;&nbsp; Capsules &nbsp;&nbsp;&nbsp; Eye Drops &nbsp;&nbsp;&nbsp; Lotions, Creams, Ointments, or Gels &nbsp;&nbsp;&nbsp; Nasal or Mouth Sprays &nbsp;&nbsp;&nbsp; Injections Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Pharmacy This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sumitomo &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Cipla &nbsp;&nbsp;&nbsp; LEO Pharma &nbsp;&nbsp;&nbsp; Abbott Laboratories &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; Tianjin Tianyao Pharmaceuticals Co., Ltd. &nbsp;&nbsp;&nbsp; Zhejiang Xianju Pharmaceutical Co.,Ltd &nbsp;&nbsp;&nbsp; Shandong Xinhua Pharmaceutical Company Limited &nbsp;&nbsp;&nbsp; Yangzi River Pharmaceutical Group Key Questions Addressed in this Report What is the 10-year outlook for the global Corticosteroid Medication market? What factors are driving Corticosteroid Medication market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Corticosteroid Medication market opportunities vary by end market size? How does Corticosteroid Medication break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Corticosteroid Medication Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Corticosteroid Medication by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Corticosteroid Medication by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Corticosteroid Medication Segment by Type &nbsp;2.2.1 Tablets &nbsp;2.2.2 Capsules &nbsp;2.2.3 Eye Drops &nbsp;2.2.4 Lotions, Creams, Ointments, or Gels &nbsp;2.2.5 Nasal or Mouth Sprays &nbsp;2.2.6 Injections &nbsp;2.3 Corticosteroid Medication Sales by Type &nbsp;2.3.1 Global Corticosteroid Medication Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Corticosteroid Medication Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Corticosteroid Medication Sale Price by Type (2020-2025) &nbsp;2.4 Corticosteroid Medication Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Pharmacy &nbsp;2.5 Corticosteroid Medication Sales by Application &nbsp;2.5.1 Global Corticosteroid Medication Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Corticosteroid Medication Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Corticosteroid Medication Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Corticosteroid Medication Breakdown Data by Company &nbsp;3.1.1 Global Corticosteroid Medication Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Corticosteroid Medication Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Corticosteroid Medication Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Corticosteroid Medication Revenue by Company (2020-2025) &nbsp;3.2.2 Global Corticosteroid Medication Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Corticosteroid Medication Sale Price by Company &nbsp;3.4 Key Manufacturers Corticosteroid Medication Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Corticosteroid Medication Product Location Distribution &nbsp;3.4.2 Players Corticosteroid Medication Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Corticosteroid Medication by Geographic Region &nbsp;4.1 World Historic Corticosteroid Medication Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Corticosteroid Medication Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Corticosteroid Medication Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Corticosteroid Medication Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Corticosteroid Medication Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Corticosteroid Medication Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Corticosteroid Medication Sales Growth &nbsp;4.4 APAC Corticosteroid Medication Sales Growth &nbsp;4.5 Europe Corticosteroid Medication Sales Growth &nbsp;4.6 Middle East & Africa Corticosteroid Medication Sales Growth 5 Americas &nbsp;5.1 Americas Corticosteroid Medication Sales by Country &nbsp;5.1.1 Americas Corticosteroid Medication Sales by Country (2020-2025) &nbsp;5.1.2 Americas Corticosteroid Medication Revenue by Country (2020-2025) &nbsp;5.2 Americas Corticosteroid Medication Sales by Type (2020-2025) &nbsp;5.3 Americas Corticosteroid Medication Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Corticosteroid Medication Sales by Region &nbsp;6.1.1 APAC Corticosteroid Medication Sales by Region (2020-2025) &nbsp;6.1.2 APAC Corticosteroid Medication Revenue by Region (2020-2025) &nbsp;6.2 APAC Corticosteroid Medication Sales by Type (2020-2025) &nbsp;6.3 APAC Corticosteroid Medication Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Corticosteroid Medication by Country &nbsp;7.1.1 Europe Corticosteroid Medication Sales by Country (2020-2025) &nbsp;7.1.2 Europe Corticosteroid Medication Revenue by Country (2020-2025) &nbsp;7.2 Europe Corticosteroid Medication Sales by Type (2020-2025) &nbsp;7.3 Europe Corticosteroid Medication Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Corticosteroid Medication by Country &nbsp;8.1.1 Middle East & Africa Corticosteroid Medication Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Corticosteroid Medication Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Corticosteroid Medication Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Corticosteroid Medication Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Corticosteroid Medication &nbsp;10.3 Manufacturing Process Analysis of Corticosteroid Medication &nbsp;10.4 Industry Chain Structure of Corticosteroid Medication 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Corticosteroid Medication Distributors &nbsp;11.3 Corticosteroid Medication Customer 12 World Forecast Review for Corticosteroid Medication by Geographic Region &nbsp;12.1 Global Corticosteroid Medication Market Size Forecast by Region &nbsp;12.1.1 Global Corticosteroid Medication Forecast by Region (2026-2031) &nbsp;12.1.2 Global Corticosteroid Medication Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Corticosteroid Medication Forecast by Type (2026-2031) &nbsp;12.7 Global Corticosteroid Medication Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Sumitomo &nbsp;13.1.1 Sumitomo Company Information &nbsp;13.1.2 Sumitomo Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.1.3 Sumitomo Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Sumitomo Main Business Overview &nbsp;13.1.5 Sumitomo Latest Developments &nbsp;13.2 Pfizer &nbsp;13.2.1 Pfizer Company Information &nbsp;13.2.2 Pfizer Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.2.3 Pfizer Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Pfizer Main Business Overview &nbsp;13.2.5 Pfizer Latest Developments &nbsp;13.3 Novartis &nbsp;13.3.1 Novartis Company Information &nbsp;13.3.2 Novartis Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.3.3 Novartis Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis Main Business Overview &nbsp;13.3.5 Novartis Latest Developments &nbsp;13.4 Merck &nbsp;13.4.1 Merck Company Information &nbsp;13.4.2 Merck Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.4.3 Merck Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Merck Main Business Overview &nbsp;13.4.5 Merck Latest Developments &nbsp;13.5 Sanofi &nbsp;13.5.1 Sanofi Company Information &nbsp;13.5.2 Sanofi Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.5.3 Sanofi Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi Main Business Overview &nbsp;13.5.5 Sanofi Latest Developments &nbsp;13.6 Johnson & Johnson &nbsp;13.6.1 Johnson & Johnson Company Information &nbsp;13.6.2 Johnson & Johnson Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.6.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Johnson & Johnson Main Business Overview &nbsp;13.6.5 Johnson & Johnson Latest Developments &nbsp;13.7 GSK &nbsp;13.7.1 GSK Company Information &nbsp;13.7.2 GSK Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.7.3 GSK Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 GSK Main Business Overview &nbsp;13.7.5 GSK Latest Developments &nbsp;13.8 AstraZeneca &nbsp;13.8.1 AstraZeneca Company Information &nbsp;13.8.2 AstraZeneca Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.8.3 AstraZeneca Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 AstraZeneca Main Business Overview &nbsp;13.8.5 AstraZeneca Latest Developments &nbsp;13.9 Cipla &nbsp;13.9.1 Cipla Company Information &nbsp;13.9.2 Cipla Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.9.3 Cipla Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Cipla Main Business Overview &nbsp;13.9.5 Cipla Latest Developments &nbsp;13.10 LEO Pharma &nbsp;13.10.1 LEO Pharma Company Information &nbsp;13.10.2 LEO Pharma Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.10.3 LEO Pharma Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 LEO Pharma Main Business Overview &nbsp;13.10.5 LEO Pharma Latest Developments &nbsp;13.11 Abbott Laboratories &nbsp;13.11.1 Abbott Laboratories Company Information &nbsp;13.11.2 Abbott Laboratories Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.11.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Abbott Laboratories Main Business Overview &nbsp;13.11.5 Abbott Laboratories Latest Developments &nbsp;13.12 Bayer &nbsp;13.12.1 Bayer Company Information &nbsp;13.12.2 Bayer Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.12.3 Bayer Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Bayer Main Business Overview &nbsp;13.12.5 Bayer Latest Developments &nbsp;13.13 Tianjin Tianyao Pharmaceuticals Co., Ltd. &nbsp;13.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information &nbsp;13.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Main Business Overview &nbsp;13.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Latest Developments &nbsp;13.14 Zhejiang Xianju Pharmaceutical Co.,Ltd &nbsp;13.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information &nbsp;13.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Main Business Overview &nbsp;13.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Latest Developments &nbsp;13.15 Shandong Xinhua Pharmaceutical Company Limited &nbsp;13.15.1 Shandong Xinhua Pharmaceutical Company Limited Company Information &nbsp;13.15.2 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Shandong Xinhua Pharmaceutical Company Limited Main Business Overview &nbsp;13.15.5 Shandong Xinhua Pharmaceutical Company Limited Latest Developments &nbsp;13.16 Yangzi River Pharmaceutical Group &nbsp;13.16.1 Yangzi River Pharmaceutical Group Company Information &nbsp;13.16.2 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolios and Specifications &nbsp;13.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Yangzi River Pharmaceutical Group Main Business Overview &nbsp;13.16.5 Yangzi River Pharmaceutical Group Latest Developments 14 Research Findings and Conclusion

Report	Global Corticosteroid Medication Market Growth 2025-2031
Selected License	Multi ID: LPI39088

Buyer Information

Order Summary